Jobs
View more job listings or post a job
Johnson & Johnson Scientist, DMPK, Biotransformation
Agios Pharmaceuticals Associate Director, DMPK/Clinical Pharmacology Agios is committed to applying our scientific leadership in cellular metabolism to transform the lives of patients with cancer and rare disease.</p
Pliant Therapeutics, Inc. DMPK, Senior Research Associate
Bristol Myers Squibb Sr Research Investigator for Redwood City, CA Location
Merck ADME Principal Scientist
ChemoCentryx Inc. Scientist (Scientist II, Senior Scientist or Principal Scientists) – Drug Metabolism, Pharmacokinetics & Clinical Pharmacology
Nektar Therapeutics Associate Director, Clinical Pharmacology
Genentech / Roche Contractor Scientific Researcher(SR)/Senior Scientific Researcher(SSR)– Mass Spectrometry
Genentech Scientific Researcher/Sr. Scientific Researcher, In Vitro DMPK/Mass Spectrometry
Genentech Scientific Researcher/Senior Scientific Researcher  in Purification Group Supporting Discovery Chemistry
Post a job

Workshop

Vendor Forum: Tools and Techniques for Bioavailability Enhancements


Speakers: Janice Cacace, PhD (CoreRx), Joseph Zeleznik (Meggle), Wolfgang Beier, PhD (leon-Nanodrugs), Konstantin Tsinman, PhD (Pion)
Organizers: Carrie Liu
Date: 1/26/2018
Time: 8:30-13:00
Registration fee (USD): Regular (including buffet lunch): $50; For Academic / unemployed (including buffet lunch): $50;
Location: Boston Marriott Cambridge (50 Broadway, Cambridge, MA)
Major Sponsor:
Vendor show vendors registered to date: (1)Intertek
Registration: http://www.PBSS.org
Registration deadline:1/26/2018  (it will close sooner if the seating cap is reached)

About the Topic

The vast majority of new molecular entities discovered today have poor solubility and/or permeability. Neither of these characteristics is beneficial for good bioavailability. This workshop will review the landscape of tools and techniques currently available to formulators, and present case studies to help overcome these challenges, topics including:

  • Formulation approaches to bioavailability enhancement
  • The use of co-processed excipients to facilitate formulation and processing of bioavailability enhancing technologies
  • Technology approaches to bioavailability enhancement including a detailed look at the benefits of nano-particles.
  • A review of the landscape of in-vitro analytical tools available to predict bioavailability enhancement, including a detailed look at a novel predictive tool to measure permeability.

About the Speakers

Dr. Janice Cacace currently leads the Product Development group at CoreRx, a CDMO based in Clearwater, FL. Dr. Cacace’s career has spanned over 30 years in the pharmaceutical industry in the areas of formulation, product development, consulting and academia. She has held management level positions involved in pharmaceutical product development for 15 years at various CDMO and pharmaceutical organizations. Her experience covers a wide range of dosage forms and product types including tablets, capsules, spray-dried dispersions, wet and dry granulations, soft gelatin capsules, oral liquids, topicals, injectables and medical foods that cover both generic and new chemical entities. Dr. Cacace holds a Bachelor of Science Degree in Pharmacy from Purdue University, and a PhD in Pharmaceutics from the University of Florida.

Mr. Joseph Zeleznik serves as Manager of Technical & Regulatory Affairs with MEGGLE USA. In his role, he is responsible for providing formulation and product application guidance as well as having quality and regulatory oversight for MEGGLE USA’s North American lactose manufacture. Prior to joining MEGGLE USA, Mr. Zeleznik was Associate Director, R&D with JRS PHARMA and Research Manager with Penwest Pharmaceuticals Co. Mr. Zeleznik has over 20 years experience in the pharmaceutical industry, having specialized in the development and application of high functionality excipients and in particular, co-processing applications for the enhancement of excipient and pharmacologically active ingredient performance. He holds several patents in areas of product and process development, formulation development, and API co-processing. Mr. Zeleznik has authored or co-authored several articles published in various industry journals. He holds a Master’s Degree in Chemistry from the State University of New York.

Dr. Wolfgang Beier is the founder and current CSO at leon-nanodrugs, a proprietary nanotechnology company leveraging it’s Microject Reactor (MJR) platform to help overcome bioavailability challenges via co-development projects with pharmaceutical and biotech companies for current and new molecular entities. Dr. Beier has 35+ years of R&D experience in the international pharmaceutical industry. He has held top executive management R&D positions in various pharma companies, and was founder and CEO of PFK Pharma Research, CEO of PFK-ILEX Oncology, and co-founder and CEO of Oncology World, Munich. Dr. Beier holds a PhD in Clinical Pharmacology from the University of Hamburg.

Dr. Konstantin Tsinman is the Chief Scientific Officer at Pion Inc., and has been with the company since 1998, where he originally joined as principal developer of the high throughput permeability analyzer, and subsequently the HT method for measuring solubility – pH profiles. Dr. Tsinman’s current interests include investigating physicochemical factors influencing absorption of pharma compounds; expanding the scope of applications for in situ UV fiber-optic techniques including real time concentration monitoring of multi-component systems, and developing in vivo predictive dissolution – absorption methods. He has co-authored more than 25 articles published in primary scientific journals and holds several patents. Dr. Tsinman received his PhD in Physics in 1994 from the Institute for Metal Physics, Kiev, Ukraine.

©Pharmaceutical & BioScience Society, International; Last Modified: 1/18/2018; Visited: 459518; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
Charles River 2nd Annual Viral Summit The 2-day summit unites industry experts in an interactive setting to share updates and discuss trends in viral safety and viral clearance.
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
Simulations Plus Are you ready to integrate in silico modeling & simulation to augment your research activities, but don’t have the time or resources? We can help!
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
Protein Characterization Seminar hosted by Charles River Join us in San Diego on September 15, 2017 to discuss the analytical methods used to detect process residuals and determine biosimilarity.
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact: kelvin.lam@reactionbiology.com
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
Simulations Plus GastroPlus™ developers launch PKPlus™. Generate validated PK reports for regulatory submissions. Value pricing/licensing. Request an evaluation today.
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Nuventra Pharma Sciences With a background in clinical pharmacology and PK/PD, Nuventra enables our clients to make better strategic decisions.
Simulations Plus The new ADMET Predictor™ 8.1 provides #1-rated ADME-Tox predictions with improved performance for large libraries. Request an evaluation today!
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Submit a Text Ad